Bessemer Group’s Intellipharmaceuticals International Inc. IPCI Stock Holding History

Bessemer Group’s Portfolio IPCI Stock Details IPCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-430	Closed	–	–	2090
2018 Q4	$0	Buy	+430	New	+$265	﹤0.01%	2114

Bessemer Group's IPCI Position: Q1 2019 in Review

Bessemer Group sold out of Intellipharmaceuticals International Inc. (IPCI) in Q1 2019, closing a stake of 430 shares.

Bessemer Group first reported a position in IPCI in Q4 2018 and held it in 1 quarter. The position peaked at $0 in Q4 2018. 0 funds tracked by Wall St. Rank hold IPCI as of Q1 2019.

Bessemer Group reported no remaining Intellipharmaceuticals International Inc. position as of Q1 2019 after selling out during the quarter.
Bessemer Group sold 430 Intellipharmaceuticals International Inc. shares in Q1 2019.
Bessemer Group first reported a position in Intellipharmaceuticals International Inc. in Q4 2018 and held it in 1 quarter.
Bessemer Group's Intellipharmaceuticals International Inc. position peaked at $0 in Q4 2018.
0 funds tracked by Wall St. Rank held Intellipharmaceuticals International Inc. as of Q1 2019.

Based on Bessemer Group's 13F filing for Q1 2019, filed 13 May 2019.